Phlebolymphology N°108 – Editorial
In this new issue of Phlebolymphology, you will find the articles as below:
Chronic venous disease is multifactorial. A. RAIKER and N. LABROPOULOS (USA) examine in depth some of the most important factors that impede venous return and explain their dynamics and association within the spectrum of chronic venous disease.
In treatment of varicose veins, risk of recurrence has always been known and can have several origins. Currently, the most widely accepted cause is recurrence attributed to the anterior accessory saphenous vein. However, the anatomy of this vein varies greatly. A. S. LENSEL and J. L. GERARD (FRANCE) discuss the pertinence of a preventive treatment for an accessory anterior vein when that vein is competent and when it’s practically feasible.
M. ENGIN (TURKEY) presents the clinical results of various treatments, including sclerotherapy, laser therapy, thermocoagulation, and microphlebectomy for telangiectasias, which make up a heterogeneous group of diseases that can affect various parts of the body in humans.
May-Thurner syndrome, known for decades as a unique pathology, has recently been included with other pelvic compression maladies in the S-V-P CEAP classification (symptoms-varices pathophysiology, clinical-etiology-anatomy-pathophysiology)—sponsored by the American Venous and Lymphatic Society—as part of several anatomic lesions in the abdominopelvic region having variable clinical presentations. R. ARMENTA-FLORES (MEXICO) provides an overview of the diagnosis and management of May-Thurner syndrome.
Although both endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) follow the principle of thermal ablation for varicose veins, there are fundamental differences in the mechanism of ablation, device used, procedure, outcomes, and complications. S. DAHAL, R. M. KARMACHARYA, and colleagues (NEPAL) discuss the principles and differences between EVLA and RFA techniques for the treatment of varicose veins.
Lastly, iliac vein stenosis is a commonly present lesion in the general population and remains silent in the majority of individuals. S. RAJU (USA) provides an up-to-date review of investigations regarding identification and treatment of iliac venous stenosis.
Enjoy reading this issue!
Dr. H. Pelin Yaltirik